The project develops, produces and sells in vitro diagnostic reagents and supporting equipment and instruments. The product market covers a number of target testing technology areas such as respiratory, eugenics, infectious disease, EBV, hand, foot and mouth, hepatitis, oncology, liver fibrosis, hypertension, diabetes, thyroid function, reproductive endocrine, autoantibody production, etc. Project management is part of the in vitro diagnostic services sector of the pharmaceutical manufacturing industry.

In vitro diagnostic technology is rapidly developing and has become one of the most active and fastest growing industries in the healthcare market. The development of in vitro diagnostic technology is the major infectious disease driving the growth of the in vitro diagnostic market.

By product type, the global in vitro diagnostics market mainly consists of POCT ODM, immunodiagnostics, biochemical diagnostics, microbiology diagnostics, molecular diagnostics, hematology diagnostics, histocytology diagnostics, etc. Among them, POCT and immunodiagnostics have the highest market shares, reaching 27% and 24% respectively.

In terms of regional distribution, the global in vitro diagnostic technology market is unevenly distributed, with high demand and growth potential. In the future, China will gradually become one of the most promising regional activities for the development of in vitro diagnostic information industry in the context of its huge population base and fast and stable economic growth.

China's in vitro diagnostic industry has entered the industrialization process. Compared with developed countries in Europe and the United States, there is a large gap in the overall technology level of the industry. In recent years, with the aging of population structure and the improvement of people's quality of life, the investment in medical and health care industry has been increasing. Domestic diagnostic reagent manufacturers have good opportunities for rapid development, and the in vitro diagnostic industry has become one of the most active and fastest growing industries in China.

In recent years, China's immunodiagnostic reagents and real-time diagnostic reagents have developed rapidly, accounting for 31% and 22% of the market share of China's entire in vitro diagnostic reagent industry respectively as of 2017, while the more mature biochemical diagnostic reagents still occupy an important market position with a market share of 10%.

Posted by: shefuzuo at 08:59 AM | No Comments | Add Comment
Post contains 357 words, total size 3 kb.